Open AccessP778: LONG‐TERM UTILIZATION AND BENEFIT OF LUSPATERCEPT IN PATIENTS (PTS) WITH LOWER‐RISK MYELODYSPLASTIC SYNDROMES (LR‐MDS) FROM THE MEDALIST TRIAL
Author(s) -
Fenaux P.,
Santini V.,
Komrokji R. S.,
Zeidan A.,
GarciaManero G.,
Buckstein R.,
Miteva D.,
Keeperman K.,
Holot N.,
Zhang J.,
Nadal J. A.,
Rosettani B.,
Yucel A.,
Platzbecker U.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000845996.15086.2d
Subject(s) - medicine , myelodysplastic syndromes , anemia , lenalidomide , clinical endpoint , clinical trial , phases of clinical research , surgery , bone marrow , multiple myeloma